1)小暮美津子・島川真知子・加藤昌久・他:Behçet病における続発眼病変.眼臨 77:1714-1721,1983
2)Elgin U, Berker N, Batman A:Incidence of secondary glaucoma in Behçet's disease. J Glaucoma 13:441-444, 2004
3)池脇淳子・瀧田真裕子・久保田敏昭:大分大学医学部眼科におけるぶどう膜炎の臨床統計.臨眼 66:61-66,2010
4)Takahashi T, Ohtani S, Miyata K et al:A clinical evaluation of uveitis-associated secondary glaucoma. Jpn J Ophthalmol 46:556-562, 2002
5)日本緑内障学会緑内障診療ガイドライン作成委員会:緑内障診療ガイドライン(第3版).日眼会誌 116:30-35,2012
6)中村 聡・杉田美由紀・田中俊一・他:ベーチェット病患者における末梢血単球のin vitro tumor necrosis factor-alpha産生能.日眼会誌 96:1282-1285,1992
7)Chen CW:Enhanced intraocular pressure controlling effectiveness of trabeculectomy by local application of mitomycin-C. Trans Asia-Pac Acad Ophthalmol 9:172-177, 1983
8)Yamamoto T, Varani J, Soong HK et al:Effects of 5-fluorouracil and mitomycin C on cultured rabbit subconjunctival fibroblast. Ophthalmology 97:1204-1210, 1990
9)Kitazawa Y, Kawase, K, Matsushita H et al:Trabeculectomy with mitomycin. A comparative study with fluorouracil. Arch Ophthalmol 109:1693-1698, 1991
10)Elgin U, Berker N, Batman A et al:Trabeculectomy with mitomycin C in secondary glaucoma associated with Behçet disease. J Glaucoma 16:68-72, 2007
11)Yalvac IS, Sungur G, Turhan E et al:Trabeculectomy with mitomycin-C in uveitic glaucoma associated with Behçet disease. J Glaucoma 13:450-453, 2004
12)嶋田博文・砂原伸彦・吉玉珠美・他:Taclolimusとinfliximab使用例における人工関節置換術後感染の経験.九州リウマチ 26:135-139,2007
13)鈴木重成・妹尾 正:TNF阻害治療中に併発白内障手術を施行したベーチェット病の1症例.眼臨紀 1:1168-1171,2008
14)Sakai T, Kanetaka A, Noro T et al:Intraocular surgery in patients receiving infliximab therapy for Behçet disease. Jpn J Ophthalmol 54:360-361, 2010
15)Koike A, Handa T, Zako M:Trabeculotomy in a Behçet's disease patient one week after infliximab administration. Case Rep Ophthalmol 3:151-155, 2012
16)Kruh JN, Yang P, Suelves AM et al:Infliximab for the treatment of refractory noninfectious uveitis. A study of 88 patients with long-term follow-up. Ophthalmology 121:358-364, 2014